Business Context and Reporting Period
Company: Medirom Healthcare Technologies Inc. (MRM)
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: A Japanese provider of holistic health services operating three segments: Relaxation Salons (core business), Luxury Beauty (hair salons), and Digital Preventative Healthcare (wearables and apps). The company operates 308 relaxation salons as of year-end, primarily in the Tokyo metropolitan area.
Key Financial Metrics
| Metric | 2024 (JPY '000) | 2024 (USD '000) | 2023 (JPY '000) | 2023 (USD '000) |
|---|---|---|---|---|
| Total Revenue | 8,299,134 | 52,736 | 6,827,943 | 43,388 |
| Net Income | 138,191 | 878 | 115,049 | 731 |
| Operating Income (Loss) | (18,102) | (115) | (391,579) | (2,489) |
| Adjusted EBITDA | 417,467 | 2,653 | 306,324 | 1,947 |
| Adjusted EBITDA Margin | 5.0% | 5.0% | 4.5% | 4.5% |
| Cash and Cash Equivalents | 329,399 | 2,093 | 106,347 | 676 |
| Total Debt (Principal) | 1,876,679 | 11,925 | 1,342,983 | 8,534 |
| Net Cash Used in Operating Activities | (1,331,681) | (8,462) | (631,737) | (4,014) |
Note: USD conversions based on exchange rate of JPY 157.37 = US$1.00 as of December 31, 2024.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 21.5% year-over-year, driven primarily by a 22.9% increase in the Relaxation Salon segment. This growth was fueled by a significant increase in revenue from the sale of directly-owned salons to investors (JPY 2.22 billion in 2024 vs. JPY 1.01 billion in 2023).
- Profitability: Operating loss narrowed significantly from JPY 391.6 million in 2023 to JPY 18.1 million in 2024. Net income increased 20.1% to JPY 138.2 million.
- Digital Segment Decline: The Digital Preventative Healthcare segment revenue decreased 23.3% to JPY 153.6 million due to temporary shipment suspensions of the MOTHER Bracelet caused by technical issues (static electricity and data connectivity).
- Impairment Charges: The company recognized an impairment loss on long-lived assets of JPY 22.9 million in 2024, compared to none in 2023.
- Debt Levels: Total indebtedness increased to JPY 1.88 billion, including new convertible bonds issued to Triple One Investment Partnership (JPY 300 million) and amended terms on bonds held by Kufu Company Inc.
Guidance, Outlook, Risks, and Contingencies
Going Concern Warning
Management has concluded that substantial doubt exists regarding the company's ability to continue as a going concern for at least 12 months following the issuance of the financial statements. While the company reported positive net income, it had negative cash flows from operations and a working capital deficit. Management plans to address this through additional capital raising (equity or debt) and continued sales of salons to investors.
Strategic Outlook
- Acquisition of JGMC: The company entered into an agreement to acquire 70% of Japan Gene Medicine Corporation (JGMC) for JPY 2.0 billion. Financing is currently being negotiated with banks. Failure to secure financing could delay or cancel the deal.
- Salon Sales Model: The company continues to pursue an asset-light strategy by selling owned salons to investors and managing them for a fee. In 2024, 60 salons were sold.
- Digital Health Recovery: Technical issues with the MOTHER Bracelet have been resolved. The company expects to fulfill over 25,000 units of purchase orders received in late 2024 during 2025.
Key Risks
- Nasdaq Listing Compliance: The company received a notification from Nasdaq on February 27, 2025, stating it is not in compliance with the minimum bid price requirement ($1.00 per share). The company has 180 days (until August 26, 2025) to regain compliance or face potential delisting.
- Internal Controls: The company identified material weaknesses in internal control over financial reporting, including insufficient review of journal entries, lack of management review controls, and ineffective user access controls.
- Liquidity: Reliance on selling salons and raising external capital to fund operations and the JGMC acquisition.
Investor Verification Checklist
- Going Concern Status: Verify the company's progress in securing additional financing or refinancing debt to alleviate the substantial doubt raised in the audit report.
- Nasdaq Compliance: Monitor the ADS bid price to ensure it meets the $1.00 threshold for 10 consecutive business days before the August 26, 2025 deadline.
- JGMC Acquisition Financing: Confirm whether the company has secured the necessary bank loans to fund the JPY 2.0 billion acquisition of Japan Gene Medicine Corporation.
- Internal Control Remediation: Review future filings for evidence of remediation regarding the identified material weaknesses in financial reporting controls.
- Digital Segment Recovery: Track the fulfillment of the 25,000+ MOTHER Bracelet orders and the resulting revenue recognition in 2025.